The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression-Reference-Cited by-同舟云学术

The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression

Published:2015-07-02 Issue:1 Volume:75 Page:75-83
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Atsumi Tatsuya,Yamamoto Kazuhiko,Takeuchi Tsutomu,Yamanaka Hisashi,Ishiguro Naoki,Tanaka Yoshiya,Eguchi Katsumi,Watanabe Akira,Origasa Hideki,Yasuda Shinsuke,Yamanishi Yuji,Kita Yasuhiko,Matsubara Tsukasa,Iwamoto Masahiro,Shoji Toshiharu,Okada Toshiyuki,van der Heijde Désirée^ORCID,Miyasaka Nobuyuki,Koike Takao

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference32 articles.

1. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA;Nam;Ann Rheum Dis,2010

2. Radiographic imaging: the ‘gold standard’ for assessment of disease progression in rheumatoid arthritis;van der Heijde;Rheumatology (Oxford),2000

3. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention;Quinn;Clin Exp Rheumatol,2003

4. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update;Smolen;Ann Rheum Dis,2014

5. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis;Singh;Arthritis Care Res,2012

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis;Rheumatology;2024-09-02

2. Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set;Annals of the Rheumatic Diseases;2024-05-22

3. Methotrexate dosage and dosing in Japan;International Journal of Rheumatic Diseases;2024-05

4. Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J);Modern Rheumatology;2024-03-06

5. Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial;Arthritis & Rheumatology;2024-01-18